Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody-associated disease: a systematic review and meta-analysis.

Qi-Lun LaiYin-Xi ZhangMeng-Ting CaiYang ZhengSong QiaoGao-Li FangChun-Hong Shen

Published in: Therapeutic advances in neurological disorders (2021)

The study provided evidence to support the efficacy of RTX, MMF, and AZA on the preventive treatment in patients with MOGAD. However, large randomized controlled trials are still needed in the future.

Keyphrases

randomized controlled trial
current status
systematic review
clinical trial
multiple sclerosis
mesenchymal stem cells
study protocol
bone marrow
double blind